Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9

Nature Communications

Volumn 5, Issue , 2014, Pages

  Shi, Mude ^a   Cho, Hyelim ^a   Inn, Kyung Soo ^a,b   Yang, Aerin ^c   Zhao, Zhen ^a   Liang, Qiming ^a   Versteeg, Gijs A ^d,e   Amini Bavil Olyaee, Samad ^a   Wong, Lai Yee ^a   Zlokovic, Berislav V ^a   Park, Hee Sung ^c   García Sastre, Adolfo ^e   Jung, Jae U ^a,f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Kyung Hee University   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d MAX F PERUTZ LABORATORIES   (Austria)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; BRAIN PROTEIN; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PROTEIN P100; PROTEIN P50; RETINOIC ACID INDUCIBLE PROTEIN I; RING FINGER PROTEIN; SYNAPTOTAGMIN I; TRIPARTITE MOTIF PROTEIN 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; NERVE PROTEIN; PRIMER DNA; SMALL INTERFERING RNA; TRIM9 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

BRAIN; ENZYME ACTIVITY; GENE EXPRESSION; HORMONE; INHIBITOR; PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; CONFOCAL MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GENETICS; HEK293 CELL LINE; HELA CELL LINE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; PLASMID; POLYMERASE CHAIN REACTION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; BRAIN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICROSCOPY, CONFOCAL; NERVE TISSUE PROTEINS; NF-KAPPA B; PLASMIDS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84920285386     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5820     Document Type: Article

References (58)

1. Staudt, L. M. Oncogenic activation of NF-kappaB. Cold Spring Harb. Perspect. Biol. 2, a000109 (2010).
2. Ruland, J. Return to homeostasis: downregulation of NF-kappaB responses. Nat. Immunol. 12, 709-714 (2011).
3. Hayden, M. S. & Ghosh, S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26, 203-234 (2012).
4. Oeckinghaus, A., Hayden, M. S. & Ghosh, S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 12, 695-708 (2011).
5. Skaug, B., Jiang, X. & Chen, Z. J. The role of ubiquitin in NF-kappaB regulatory pathways. Annu. Rev. Biochem. 78, 769-796 (2009).
6. Vallabhapurapu, S. & Karin, M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733 (2009).
7. Sun, S. C. Non-canonical NF-kappaB signaling pathway. Cell Res. 21, 71-85 (2011).
8. Razani, B., Reichardt, A. D. & Cheng, G. Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives. Immunol. Rev. 244, 44-54 (2011).
9. Perkins, N. D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62 (2007).
10. Chen, Z. J. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 7, 758-765 (2005).
11. Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438-449 (2008).
12. Xiao, G., Harhaj, E. W. & Sun, S. C. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 7, 401-409 (2001).
13. Senftleben, U. et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293, 1495-1499 (2001).
14. Liang, C., Zhang, M. & Sun, S. C. beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870. Cell Signal. 18, 1309-1317 (2006).
15. Skaar, J. R., D'Angiolella, V., Pagan, J. K. & Pagano, M. SnapShot: F box proteins II. Cell 137, 1358 (2009).
16. Graff, J. W., Ettayebi, K. & Hardy, M. E. Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism. PLoS Pathog. 5, e1000280 (2009).
17. Spardy, N. et al. Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Cancer Res. 69, 7022-7029 (2009).
18. Reviriego-Mendoza, M. M. & Frisque, R. J. Interaction and co-localization of JC virus large T antigen and the F-box protein beta-transducin-repeat containing protein. Virology 410, 119-128 (2011).
19. Blanchet, F. P., Mitchell, J. P. & Piguet, V. beta-TrCP dependency of HIV-1 Vpu-induced downregulation of CD4 and BST-2/Tetherin. Curr. HIV Res. 10, 307-314 (2012).
20. Kanarek, N. & Ben-Neriah, Y. Regulation of NF-kappaB by ubiquitination and degradation of the IkappaBs. Immunol. Rev. 246, 77-94 (2012).
21. Hatakeyama, S. TRIM proteins and cancer. Nat. Rev. Cancer 11, 792-804 (2011).
22. Jefferies, C., Wynne, C. & Higgs, R. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat. Rev. Immunol. 11, 617-625 (2011).
23. Kawai, T. & Akira, S. Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins. EMBO Mol. Med. 3, 513-527 (2011).
24. McNab, F. W., Rajsbaum, R., Stoye, J. P. & O'Garra, A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23, 46-56 (2011).
25. Ozato, K., Shin, D. M., Chang, T. H. & Morse, 3rd H. C. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8, 849-860 (2008).
26. Newman, R. M. & Johnson, W. E. A brief history of TRIM5alpha. AIDS Rev. 9, 114-125 (2007).
27. Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007).
28. Tsuchida, T. et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33, 765-776 (2010).
29. Shi, M. et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9, 369-377 (2008).
30. Hu, Y. et al. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production. J. Immunol. 185, 7699-7705 (2010).
31. Zha, J. et al. The Ret finger protein inhibits signaling mediated by the noncanonical and canonical IkappaB kinase family members. J. Immunol. 176, 1072-1080 (2006).
32. Berti, C., Messali, S., Ballabio, A., Reymond, A. & Meroni, G. TRIM9 is specifically expressed in the embryonic and adult nervous system. Mech. Dev. 113, 159-162 (2002).
33. Tanji, K. et al. TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol. Dis. 38, 210-218 (2010).
34. Hao, J. C. et al. The tripartite motif protein MADD-2 functions with the receptor UNC-40 (DCC) in Netrin-mediated axon attraction and branching. Dev. Cell 18, 950-960 (2010).
35. Song, S. et al. TRIM-9 functions in the UNC-6/UNC-40 pathway to regulate ventral guidance. J. Genet. Genomics 38, 1-11 (2011).
36. Xiao, G., Fong, A. & Sun, S. C. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J. Biol. Chem. 279, 30099-30105 (2004).
37. Short, K. M. & Cox, T. C. Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding. J. Biol. Chem. 281, 8970-8980 (2006).
38. Lee, S. et al. A facile strategy for selective incorporation of phosphoserine into histones. Angew. Chem. Int. Ed. Engl. 52, 5771-5775 (2013).
39. Park, H. S. et al. Expanding the genetic code of Escherichia coli with phosphoserine. Science 333, 1151-1154 (2011).
40. Rajsbaum, R., Stoye, J. P. & O'Garra, A. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur. J. Immunol. 38, 619-630 (2008).
41. Davis, M. et al. Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U. Genes Dev. 16, 439-451 (2002).
42. Bour, S., Perrin, C., Akari, H. & Strebel, K. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J. Biol. Chem. 276, 15920-15928 (2001).
43. Li, Y., Chin, L. S., Weigel, C. & Li, L. Spring, a novel RING finger protein that regulates synaptic vesicle exocytosis. J. Biol. Chem. 276, 40824-40833 (2001).
44. Pribiag, H. & Stellwagen, D. TNF-alpha downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABA(A) receptors. J. Neurosci. 33, 15879-15893 (2013).
45. Nie, H. et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat. Med. 19, 322-328 (2013).
46. Mock, T. Identification and characterisation of protein phosphatase 1, catalytic subunit alpha (PP1alpha) as a regulator of NF-kappaB in T lymphocytes. Dissertation, http://www.ub.uni-heidelberg.de/archiv/13079 (2012).
47. Yaguchi, H. et al. TRIM67 protein negatively regulates Ras activity through degradation of 80 K-H and induces neuritogenesis. J. Biol. Chem. 287, 12050-12059 (2012).
48. Mattson, M. P. & Meffert, M. K. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 13, 852-860 (2006).
49. Tansey, M. G. & Goldberg, M. S. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 37, 510-518 (2010).
50. Hunot, S. et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc. Natl Acad. Sci. USA 94, 7531-7536 (1997).
51. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A. & Kaltschmidt, C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 2642-2647 (1997).
52. Gutierrez, H. & Davies, A. M. Regulation of neural process growth, elaboration and structural plasticity by NF-kappaB. Trends Neurosci. 34, 316-325 (2011).
53. Reymond, A. et al. The tripartite motif family identifies cell compartments. EMBO J. 20, 2140-2151 (2001).
54. Uchil, P. D., Quinlan, B. D., Chan, W. T., Luna, J. M. & Mothes, W. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 4, e16 (2008).
55. Zhang, F., Hatziioannou, T., Perez-Caballero, D., Derse, D. & Bieniasz, P. D. Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 353, 396-409 (2006).
56. Busino, L. et al. Fbxw7alpha- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nat. Cell Biol. 14, 375-385 (2012).
57. Zandi, E., Chen, Y. & Karin, M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 281, 1360-1363 (1998).
58. Matsumura, N., Yoshida, N., Ohta, A., Miyamoto, Y. & Hisatsune, T. Neural precursor cells from adult mouse cerebral cortex differentiate into both neurons and oligodendrocytes. Cytotechnology 43, 19-25 (2003).